JILL JAMIESON: Open Payments
NPI 1891246385 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 87 payments from 21 companies in 2025. Trend: 2023 $563 · 2024 $734 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $292 |
| PFIZER INC. | 16 | $289 |
| Amgen Inc. | 10 | $175 |
| Abbott Laboratories | 5 | $104 |
| Novo Nordisk Inc | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Exact Sciences Corporation | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Corcept Therapeutics | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: UBRELVY, ELIQUIS, NURTEC ODT, FREESTYLE LIBRE 3, REXULTI, OTEZLA, Ozempic, EVENITY.
Industry payments across MI — which companies pay providers there.
